Effectiveness of Pseudoephedrine Plus Acetaminophen for Treatment of Symptoms Attributed to the Paranasal Sinuses Associated With the Common Cold

Autor: James Rogers, Ronald B. Turner, James V. Sorrentino, Robert R. O'Connor, Steven J. Sperber, Jack M. Gwaltney

Publikováno v: Archives of Family Medicine. 9:979-985

BACKGROUND Little data exist on the cause and treatment of subfacial pain and pressure and other discomfort attributed to the paranasal sinuses that develop early during the course of the common cold. The purpose of this study was to determine the ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a35309ef37ec56d6891fa4f6ba45401
https://doi.org/10.1001/archfami.9.10.979

Heat stress effects for USAF anti-G suits with and without a counter-pressure vest

Autor: Ulf I, Balldin, Robert R, O'Connor, Paul M, Werchan, Wayne M, Isdahl, Peter F, Demitry, Roger L, Stork, Thomas R, Morgan

Publikováno v: Aviation, space, and environmental medicine. 73(5)

Aircrew have reported increased heat stress when wearing the USAF Combined Advanced Technology Enhanced Design G-Ensemble or COMBAT EDGE (CE). The perceived thermal burden has been attributed to the fact that CE includes an inflatable counter-pressur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1be1aad149c8821a1dadb8e21107c925
https://pubmed.ncbi.nlm.nih.gov/12014604

How difficult is titanium plate and screw implant removal? A retrospective case series.

Autor: Dehghan N; The CORE Institute, Phoenix, AZ, United States; University of Arizona College of Medicine Phoenix, Phoenix, AZ, United States. Electronic address: niloofar.dehghan@thecoreinstitute.com., Frane N; HealthPartners Orthopedics, Minneapolis, MN, United States., Vohra A; University of Arizona College of Medicine Phoenix, Phoenix, AZ, United States., O'Connor R; The Orthopaedic Institute, Gainesville, FL, United States., Deeyor S; University of Arizona College of Medicine Phoenix, Phoenix, AZ, United States., Hui C; University of Arizona College of Medicine Phoenix, Phoenix, AZ, United States., McKee M; University of Arizona College of Medicine Phoenix, Phoenix, AZ, United States.

Publikováno v: Injury [Injury] 2024 Nov; Vol. 55 (11), pp. 111824. Date of Electronic Publication: 2024 Aug 13.

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.

Autor: Parsons MT; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia. Electronic address: michael.parsons@qimrberghofer.edu.au., de la Hoya M; Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC, 28040 Madrid Spain., Richardson ME; Ambry Genetics Corporation, Aliso Viejo, CA 92656, USA., Tudini E; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Anderson M; Invitae Corporation, San Francisco, CA, USA., Berkofsky-Fessler W; GeneDx, Gaithersburg, MD, USA., Caputo SM; Department of Genetics, Institut Curie, and Paris Sciences Lettres Research University, 75005 Paris, France., Chan RC; Color Health, Burlingame, CA, USA., Cline MS; UC Santa Cruz Genomics Institute, Genomics, University of California, 1156 High Street, Santa Cruz, CA 95064, USA., Feng BJ; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Fortuno C; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Gomez-Garcia E; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands., Hadler J; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Hiraki S; GeneDx, Gaithersburg, MD, USA., Holdren M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Houdayer C; University Rouen Normandie, Inserm U1245 and CHU Rouen, Department of Genetics, FHU G4 Génomique, F-76000 Rouen, France., Hruska K; GeneDx, Gaithersburg, MD, USA., James P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Karam R; Ambry Genetics Corporation, Aliso Viejo, CA 92656, USA., Leong HS; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia., Martins A; University Rouen Normandie, Inserm U1245, F-76000 Rouen, France., Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Monteiro AN; Department of Cancer Epidemiology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Nathan V; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., O'Connor R; Color Health, Burlingame, CA, USA., Pedersen IS; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Pesaran T; Ambry Genetics Corporation, Aliso Viejo, CA 92656, USA., Radice P; Predictive Medicine: Molecular Bases of Genetic Risk, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133 Milano, Italy., Schmidt G; Institute of Human Genetics, Hannover Medical School, 30625 Hannover, Germany., Southey M; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia; Department of Clinical Pathology, The Melbourne Medical School, The University of Melbourne, Melbourne, VIC 3010, Australia., Tavtigian S; Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84132, USA., Thompson BA; Department of Pathology, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, USA., Turnbull C; Translational Genetics Team, Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK., Vogel MJ; Department of Human Genetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Weyandt J; Ambry Genetics Corporation, Aliso Viejo, CA 92656, USA., Wiggins GAR; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Zec L; Natera, Inc, San Carlos, CA, USA., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Spurdle AB; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. Electronic address: amanda.spurdle@qimrberghofer.edu.au.

Publikováno v: American journal of human genetics [Am J Hum Genet] 2024 Sep 05; Vol. 111 (9), pp. 2044-2058. Date of Electronic Publication: 2024 Aug 13.

IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance.

Autor: Walsh M; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Jordan A; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Schäfer L; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Joha J; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Heapes B; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland., Noonan M; Breakthrough Cancer Research, Cork, Ireland., Gallagher W; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland., Gallagher H; Department of Urology, Beacon Hospital, Sandyford, Dublin, Ireland., Manecksha RP; Department of Urology, Tallaght University Hospital, Dublin, Ireland; Department of Surgery, Trinity College Dublin, Dublin, Ireland., Galvin D; Department of Urology, St. Vincent's University Hospital, Dublin, Ireland., Nason G; Department of Urology, Mater Misericordiae University Hospital, Dublin, Ireland., Martin T; Clinical Research Centre, University College Dublin, Dublin, Ireland., Lyons C; Department of Radiology, Cork University Hospital, Cork, Ireland., O'Connor R; Irish Cancer Society, Dublin, Ireland., Drummond FJ; Breakthrough Cancer Research, Cork, Ireland., Kilty C; Irish Cancer Society, Dublin, Ireland., Perry AS; Cancer Biology and Therapeutics Laboratory, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; School of Biology and Environmental Science, University College Dublin, Dublin, Ireland. Electronic address: antoinette.perry@ucd.ie.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102063. Date of Electronic Publication: 2024 Mar 04.